Brown, L. C., Sedhom, R., Schwartz, E. B., Zhu, J., Kao, C., Tucker, M. D., … Armstrong, A. J. (2020). Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).

Brown, Landon Carter, Ramy Sedhom, Eric B. Schwartz, Jason Zhu, Chester Kao, Matthew D. Tucker, Matthew Labriola, et al. “Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.

Brown LC, Sedhom R, Schwartz EB, Zhu J, Kao C, Tucker MD, et al. Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.

Brown, Landon Carter, et al. “Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.

Brown LC, Sedhom R, Schwartz EB, Zhu J, Kao C, Tucker MD, Labriola M, Gupta RT, Marin D, Wu Y, Zhang T, Harrison MR, George DJ, Alva AS, Antonarakis ES, Armstrong AJ. Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types. JOURNAL OF CLINICAL ONCOLOGY. 2020.